Ginkgo bioworks announces presentations at the upcoming american society of gene & cell therapy (asgct) annual meeting

Boston , may 6, 2024 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced its participation in the 27th american society of gene & cell therapy (asgct) annual meeting, may 7-11, in baltimore, md. ginkgo will present three posters in cell therapy and give one oral presentation in mrna therapeutics.
DNA Ratings Summary
DNA Quant Ranking